NCT01668290

Brief Summary

Patients who present with chest pain are investigated with tests designed to confirm or exclude the presence of Coronary Artery Disease (CAD), as well as determine risk of poor outcome. It is not known which imaging test would be best when used first for investigating a patient presenting with exertional chest pain. This trial is designed to compare outcomes of the use of coronary CT, stress echocardiography and nuclear perfusion (SPECT) in a pilot study. Patients with no history of coronary disease presenting with chest pain will be randomly assigned to one of the three test modalities as the initial imaging test. The three imaging strategies will be compared regarding the subsequent use of healthcare resources over a year.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 13, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 20, 2012

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

March 16, 2017

Status Verified

March 1, 2017

Enrollment Period

4.5 years

First QC Date

August 13, 2012

Last Update Submit

March 15, 2017

Conditions

Keywords

Coronary Artery DiseaseStress EchocardiographySingle Photon Emission Computed TomographyCardiac Computed Tomographic Angiographyoutcomes

Outcome Measures

Primary Outcomes (1)

  • healthcare resource utilization

    12 month

Secondary Outcomes (7)

  • referral rates to coronary angiography following three different initial imaging tests in this patient population.

    12 month

  • coronary lesions which warrant revascularization (including those where it was warranted but not technically possible).

    12 month

  • radiation exposure from the initial and subsequent imaging procedures

    12 month

  • total mortality

    12 month

  • freedom from angina

    12 month

  • +2 more secondary outcomes

Study Arms (3)

Stress Echocardiography

Patients will be randomized to one of three imaging modalities. One imaging modality thay can be randomized to is Stress Echocardiography.

SPECT

Patients will be randomized to one of three imaging modalities. One imaging modality thay can be randomized to is Single Photon Emission Computed Tomography (SPECT)

CCTA

Patients will be randomized to one of three imaging modalities. One imaging modality thay can be randomized to is Cardiac Computed Tomographic Angiography (CCTA)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Men and women without known CAD who present with symptoms suggestive of CAD and require diagnostic/prognostic workup.

You may qualify if:

  • Adult Age ≥ 18 years
  • Presenting with symptoms suggestive of CAD requiring diagnostic/prognostic workup
  • Suitable for Contrast Stress Echocardiography, SPECT and CCTA
  • Able and willing to provide consent

You may not qualify if:

  • Patients with documented CAD (previous invasive angiography, previous STEMI, previous PCI or CABG)
  • NSTEMI, ACS within 3 months
  • Previous diagnostic imaging tests in the past 6 months
  • Women who are pregnant as evidenced by positive pregnancy test
  • Breast feeding females
  • Significant valvular heart disease (i.e. severe aortic stenosis or regurgitation or severe mitral regurgitation)
  • Hemodynamic instability (blood pressure \>210/110 ml/Hg or \<90/60 mm/Hg)
  • Unavailability for follow-up
  • Renal insufficiency, eGFR \< 30 ml/minute unless on dialysis
  • Known allergy to x-ray or echo contrast agents
  • Weight exceeding specifications of nuclear equipment (\>250 Kg)
  • Unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mazankowski Alberta Heart Institute

Edmonton, Alberta, T6G2B7, Canada

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Harald Becher, MD,PhD,FRCP

    University of Alberta, Alberta Health Services

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Heart and Stroke Foundation Chair for Cardiovascular Research

Study Record Dates

First Submitted

August 13, 2012

First Posted

August 20, 2012

Study Start

July 1, 2012

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

March 16, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations